Oncology Flashcards

1
Q

What are genetic associations for colorectal cancer?

A

K-ras, C-myc oncogenes and APC TSG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What tumour marker is associated with colorectal cancer?

A

Carcinoembryonic antigen (CEA) test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What imaging modality is used for staging i.e. to screen for mets? e.g. colorectal cancer

A

CT CAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the most common sites for mets in colorectal cancer?

A

Liver, lung, peritoneum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When is radiotherapy indicated in treatment of bowel cancer?

A

The small bowel and colon are mobile and difficult to target with radiotherapy, constantly in peristalsis. Radiotherapy is only used in advanced rectal caner.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What classification system is used to classify colorectal cancers?

A

Dukes classification. They are divided into limited to the bowel wall (Dukes A), extended through the bowel tissue (Dukes B), with metastases to regional lymph nodes (Dukes C) and widespread metastases (Dukes D).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When do you consider chemotherapy in colon cancer?

A

For Dukes B and C tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

An autosomal dominant condition resulting from mutation in the tumour suppressor APC gene Ch5 which causes colonic polyps.

A

Familial adematous polyposis (FAP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you manage FAP?

A

Screening from 14yo.

If >100 polyps, may require prophylactic colectomy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

An autosomal dominant condition resulting from mutations in MSH2, MSH6, MLH1, PMS2 genes, leading to defective mismatch repair. This leads to increased risk of GI and gynaecological malignancies.

A

Hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Perianal pain, bleeding, palpable lump - what is the gold standard investigation?

A

Perianal malignancy; MRI with biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do high levels of AFP indicate?

A

This is non-specific - possibly hepatocellular carcinoma, or testicular teratoma (prognostic value, for staging/ monitoring) - rapid fall post-orchidectomy implies disease localised to testis.
May also be high in liver cirrhosis, pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do high levels of CEA indicate?

A

This is non-specific - present in 60% of patients with colorectal cancer, and 80-100% for patients with advanced disease with hepatic mets
Also present in liver disease, pancreatitis, IBD, heavy smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of CEA in screening for colorectal cancer?

A

It is not a sufficiently specific or sensitive marker/ or correlate with tumour bulk - so it is not routinely used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of serum or urinary paraproteins in diagnosis of myeloma?

A

They are used in detection of myeloma, and correlates well with tumour bulk. They are a good indicator of efficacy of treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the tumour marker for choriocarcinoma (malignant growth of chorionic villi developing from malignant hydatiform mole)?

A

Beta-HCG - an almost ideal marker; very sensitive i.e. the smallest rise may indicate underlying tumour

17
Q

What markers are a/w testicular teratomas?

A

AFP and HCG

18
Q

How do you diagnose and monitor phaeochromocytomas?

A

24 hour urinary metanephrines. These must be brought quickly to the lab for acidification.

19
Q

How do you screen for medullary cell carcinoma (MTC)?

A

Blood calcitonin, also part of a pentagastrin DFT screening test. MEN2A syndrome.

20
Q

What are examples of MEN1 cancers?

A

Pituitary adenoma
Parathyroid hyperplasia
Pancreatic tumours

21
Q

What causes a rise in PSA?

A

Limited sensitivity and specificity. Prostate cancer, BPH, age can result in raised levels. DRE, prostatitis, UTI can transient raise levels.

22
Q

What are examples of MEN2A cancers?

A

Parathyroid hyperplasia
Medullary thyroid carcinoma
Phaeochromocytoma

23
Q

What serum markers do you check for bone mets?

A

Alkaline phosphatase (ALP) - this may be raised also in cholestatic liver disease, Paget’s, osteomalacia

24
Q

What tumour marker is used in diagnosis and monitoring of ovarian cancer?

A

CA125 - this is also raised in benign conditions such as endometriosis
Concentration does not correlate to prognosis; and serial measurements used to monitor post resection and chemo

25
Q

What conditions is the serum marker CA 19-9 associated with?

A

Pancreatic adenocarcinoma
Colorectal/ gastric carcinoma
PSC (rapid rise observed)

26
Q

When would CA 19-9 levels appear low in patients with pancreatic adenocarcinoma?

A

Patients with blood types Lewis a and b, who do not produce CA19-9 and this cannot be used to monitor disease

27
Q

What cancers are a/w PtHrP secretion?

A

Squamous cell lung cancer and renal adenocarcinoma. This leads to hypercalcaemia.

28
Q

What marker is used to diagnose neuroblastomas?

A

Vanillylmandelic acid (VMA) and homovanillic acid (HVA)